English
Procter & Gamble Health Q3 Results
- BSE: 500126
- NSE: PGHL
- ISIN: INE199A01012
- Sector: Biotechnology & Drugs
BSE
5,551.00
-103.10 (-1.82%)
-103.10 (-1.82%)Volume265.00
Updated: Fri 12 Dec, 2025 | 15:28:00
NSE
5,577.50-78.50 (-1.39%)
-78.50 (-1.39%)Volume4.24 K
Updated: Fri 12 Dec, 2025 | 15:54:42
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Procter & Gamble Health Q3 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | Dec 23 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 235.44 | 215.24 | 22.70% | 191.88 | 22.70% |
| Depreciation/ Amortization | 5.37 | 6.92 | -3.24% | 6.84 | -21.49% |
| Operating Income | 75.55 | 94.73 | -35.91% | 60.60 | 24.67% |
| Net Income | 61.18 | 72.07 | -32.70% | 46.56 | 31.40% |
| Other Operating Expenses Total | 82.56 | 60.50 | 29.89% | 62.72 | 31.63% |
| Net Income Before Taxes | 78.53 | 99.72 | -35.47% | 62.72 | 25.21% |
| Total Revenue | 310.99 | 309.97 | 0.39% | 252.48 | 23.17% |
| Selling/ General/ Admin Expenses Total | 48.79 | 57.43 | 3.70% | 48.46 | 0.68% |
| Diluted Normalized EPS | 36.69 | 43.40 | -33.00% | 28.00 | 31.03% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.